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Abstract 
The effectiveness of Thymus vulgaris L. Essential Oil (TvEO) for topical use in 21 sheep affected by 
mammary pustular dermatitis (MPD), not subjected to previous antibacterial therapy, was studied. After the 
evaluation of the antimicrobial susceptibility of isolated microorganisms(Staphylococcus epidermidis and 
Staphylococcus aureus) in milk samples to TvEO, some antimicrobials drugs (amoxicillin-clavulanic acid, 
doxycycline, florfenicol and enrofloxacin) and Citrus bergamia Risso et Poiteau EO (CvEO), the sheep, 
divided in two groups, were treated topically for 7 days with TvEO(13 animals) and CvEO (8 animals) 
respectively. The results showed that only TvEO induced a decrease in clinical signs 3 days after treatment 
and the complete disappearance of udder lesions after 7 days. No revival of infection was observedin the 
following months. The use of TvEOcould be an alternative to antibiotic treatment in ovine affected by MPD 
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Introduction 
In recent years, one of the most economically significant problems for a healthy sheep 
breeding is udder infections, widely diffuse in the world. Mastitis is one of the most common 
diseases in the dairy sheep, characterized by inflammatory and infectious processes, damage to 
mammary tissue and, consequently, reduced production and quality of milk. Common in ovine 
is also the mammary pustular dermatitis (MPD), aggravated by symptoms of mastitis, 
characterized by the appearance of pustules and vesicles, 2-4 mm in diameter, initially at the 
base of the teats which can then extend all over the skin of the udder. These lesions can 
develop into thick brownish irregularly circular scabs, which adhere to the underlying tissue. 
The udder appears enlarged, reddened, hot and painful on palpation, with decreased mammary 
secretion and altered chemical, physical and organoleptic characteristics of the milk. Diagnosis 
is made on clinical signs and by bacteriological testing of milk. The main pathogen 
responsible for mastitis in dairy sheep is Staphylococcus aureus, a Gram- positive organism, 
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cause of subclinical and chronic intramammary infections, often contagious.  
Other microorganisms (staphylococci, streptococci, E. coli, mycoplasma, etc.) may also cause 
mammary infections associated with the animal's immunosuppression.Various are the factors 
predisposing to udder diseases: number of parts, udder conformation, lactation, hot-humid 
climate, incorrect milking, environmental hygiene, etc.Several different therapies have been 
used to fight the various bacterial infections responsible for mastitis and MPD in sheep and to 
solve the problem of bacterial resistance of several microorganism.  
A valid alternative to traditional treatment, in order to counteract the development and spread 
of bacterial resistance, is represented by the use of essential oils (EOs), mixtures of organic 
substances, aromatic oils, biodegradable and with low toxicity, extracted from spices, aromatic 
herbs, fruit, flowers and plant material (buds, seeds, leaves, twigs, bark, wood, roots), 
effective natural products used against various infectious diseases (1, 2, 3, 4, 5).  
Currently more than 3,000 EOs are known but only 300 are widely marketed. Some EOs 
obtained from Thymus vulgaris, Zea mais, Melaleuca alternifolia, Citrus bergamia, ecc. are 
used in pharmaceuticals field because many studies report their antibacterial activity against 
many multi-resistant microbial species, such as methicillin-resistant Staphylococcus aureus 
(MRSA), vancomycin-resistant Enterococcus (VRE), Pseudomonas aeruginosa, Klebsiella 
pneumoniae, ESBL E. coli, Acinetobacter spp, Campylobacter jejuni, Listeria monocytogenes, 
Bacillus cereus, etc. (6, 7, 8, 9, 10). Other studies show that these EOs also have antifungal 
(11, 12, 13), antiviral (14), antioxidant, and anti-parasitic activity (15).Among EOs, Thymus 
vulgaris L. (TvEO) is used in dermatological, uro-gynecological and gastrointestinal diseases 
in human, for its beneficial properties due to presence of phenols, in particular, thymol (30%-
70%) and carvacrol (3%-15%), recognized as anti-inflammatory, antiseptic, antispasmodic and 
vermicide substances, for external and internal use (16, 17, 18, 19 20).Some authors confirmed 
the antifungal activity of this EOs against Candida albicans isolated from bovine clinical 
mastitis (21, 22). In our previous investigations, the efficacy of TvEO for topical use in dog 
skin infections was evaluated (23). 
The aim of the present study was to assess the effectiveness of Thymus vulgaris EO for topic 
use in ovine affected by MPD, aggravated by mastitis symptoms.  
Material and methods 
Sampling 
From a clinical screening on 530 sheep from different farms in Messina, 21 animals affected 
by MPD aggravated by mastitis symptoms, not subjected to previous antibacterial therapy, 
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were selected and milk samples were taken before and 3, 5, 7 and 15 days after the EOs 
treatment. 
Bacteriological investigations 
The milk samples, after Gram staining, were enriched on BHI broth (Biolifes. Rl, Milan, Italy) 
for 18 hours at 37 °C and isolated on MacConkey-agar (Oxoid, Basingstoke, Hampshire, UK) 
and SM-Staphylococci 110 medium (Biolifes, Milan, Italy). After incubation for 24 hours at 
37 °C, the isolated colonies were identified by Api System (bioMerieux SA, Marcy l'Etoile, 
France). 
The in vitro susceptibility of isolated microorganisms to TvEO and CbEO (KOS S.r.l. 
Comeana-PO, Italy) and to some antimicrobial drugs widely used in ovine infection 
(amoxicillin-clavulanic acid, doxycycline, florfenicol and enrofloxacin) (Liofilchem S.r.l. 
Roseto degli Abruzzi – TE, Italy) was evaluated by Kirby-Bauer test.  
Pharmacological treatment 
The 21 animals were divided, at random, into two groups: the first group consisting of 13 
sheep (n. 7 positive to Staphylococcus epidermidis and n. 4 positive to Staphylococcus aureus) 
and the second group consisting of 8 sheep (n. 4 positive to Staphylococcus epidermidis and 
n.4 positive to Staphylococcus aureus). Both groups were treated topically, by spraying the 
udder areas affected by lesions, for 7 days consecutively, with 4 ml (20 ml /L H2O) of TvEO 
and CbEO respectively. 
Clinical scores recorded before and after thetreatment 
The efficacy of TvEO was evaluated according to the presence of bacteria in the milk before, 
during and after the end of thetreatment and on the basis of the scoring system relating to the 
regression of local clinical signs (0 = absent; 1 = slight; 2 = limited; 3 =significant): such 
assensitivity to pain of the udder, increase in udder volume, presence and number of vesicles, 
pustules or scabs respectively. 
Statisticalanalysis 
The data were expressed as mean ± S.D. elaborated using an analysis of variance (ANOVA). 
InStat 3.0 software (GraphPad Software San Diego, CA, USA) was applied to assess the 
significance of the difference between the scores recorded before and 3, 5, 7 and 15 days after 
the drugs treatment. Difference with p<0.05 were considered significant.  
Results 
Bacteriological finding 
Staphylococcus epidermidis (13 strains) and Staphylococcus aureus (8 strains) have been isolated from 
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milk samples. The in vitro susceptibility of isolated strains to EOs and some antimicrobials were reported 
in Table 1. We observed that TvEOis the most active antibacterial drug in this comparative analysis. 
Pharmacological treatment 
The bacteriological findings isolated from milk samples, before and 3, 5, 7 and 15 days after the end of 
treatment for 7 days with TvEO and CbEO respectively, were reported in Table 2 
 
Table 1. In vitro susceptibility of Gram-positive microorganisms isolated from milk samplesto TvEO, CbEO and to various 
antibacterial rugs. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
+++ Susceptible; ++  Intermediate; + Poorly susceptible; - Resistant 
 
DRUGS 
Bacterial strains 
Staphylococcus epidermidis (13) Staphylococcus aureus (8) 
Thymus vulgaris EO +++ Thymus vulgaris EO 
Citrus bergamia EO ++ Citrus bergamia EO 
Amoxicillin-ac. clavulanic ++ Amoxicillin-ac. clavulanic 
Doxycycline + Doxycycline 
Florfenicol  - Florfenicol 
Enrofloxacin ++ Enrofloxacin 
Table2.Bacteriological findings isolated from milk samples before (T0baseline), 3,5,7 and15daysafter topical treatment on ovine 
affected by MPD. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
*The degree of positivity for the infection was expressed in the conventional manner (from + to ++++) in relation to the quantity of 
bacteria present. 
Thymus vulgaris EO (13 sheep) 
 T 0 3 days 5 days 7 days 15 days 
Staphylococcus epidermidis (7) ++++ +++ + - - 
Staphylococcus aureus (6)      
Citrus bergamia EO (8 sheep) 
Staphylococcus epidermidis (4) ++++ ++++ +++ +++ +++ 
Staphylococcus aureus (4) ++++ +++ +++ +++ ++ 
 
Clinical scores 
The sheep affected by MPD at the end of TvEO treatment showed decrease in the clinical 
signs after 3 and 5 days (the udder was less sensitive on palpation and less swollen) and an 
evident complete remission after 7 days (Tab.3; Fig. 1). No local or general signs of TvEO 
intolerance were recorded in any treated ovine and no relapses occurred in the month 
following treatment. The treatment with CbEO(Group 2), instead, showed no significant 
effects. 
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Table3. EffectsoftopicaltreatmentwithTvEOfor7days(mean±S.D.)and scoring of clinical signs in ovine affected by MPD. 
*p< 0,01; **p<0,05 
Clinical signs Before 
treatment 
After 3 days After 5 
days 
After 7 
days 
After 15 
ays 
Sensitivity to pain of the udder(mean ±S.D.) 2.67 ± 0.18 **1.75 ± 
0.46 
*0.37 ± 
0.12 
- - 
Increase in sudder volume(mean ±S.D.) 2.84 ± 0.58 **1.48 ± 
0.35 
*0.42 ± 
0.12 
- - 
Number of vesicles, pustules or scabs(mean 
±S.D.) 
2.37 ± 0.51 **1.37 ± 
0.51 
0.17± 0.46 - - 
 
Discussion 
Our study documents the potential therapeutic efficacy of TvEO in ovine affected by 
mammary pustular dermatitis due to Gram-positive bacteria and showsan improvement in the 
clinical symptoms after 3 and 5 days of treatment with complete healing after 7 days. 
Furthermore, no local or general adverse reactions were observed during the various stages 
of therapeutic treatment. No therapeutic effects, instead, showed CbEO used in comparison 
as a positive control in ovine suffering from MPD, caused by Gram-positivebacteria. 
The mechanism of antimicrobial activity of TvEO is quite complex and not been well 
elucidated.Some authors have observed that thymol, the main component of this oil,inhibits 
Staphylococcus aureusinternalizationintobMECbyinhibitingNF-kBactivation (22). 
However,beingThymus EO acomplex mixture,its antibacterial action at cellular level could 
be correlated not to a single mechanismbut probably to the synergic interaction of various 
organic compounds (19). The clinical studies reported in literature on EOs use in animal 
diseases are related mostly to in vitro study, for this reason it is very important to investigate 
their effectiveness and safety in vivo, as possible therapeutic alternative in veterinary 
medicine.  
In one of our previous investigation in vivo, the therapeutic efficacy of TvEO in skin 
infections of dogs was documented (23). Currently there are no studies on the topical use of 
TvEO in ovine affected by MPD. 
The results of our investigations show that the topical use of TvEO, also for its low cost, could constitute 
a possible alternative or a support to antibiotic therapy in dermatological infections, in particular in cases 
refractory to conventional therapy. This EO, in addition to showing a good antimicrobial activity, has 
other biological and therapeutic properties (antifungal, anti-inflammatory, antioxidant, etc.). In addition, 
it is believed extremely unlikely that bacteria can develop drug resistance to EOs, as these consists of 
several molecular components, compared to an antibiotic consisting of a single active substance(19). 
Moreover, it seems that EOs can affect synergistic activity with antibiotics, improving their therapeutic 
efficacy(4, 6). 
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Figure 1. Therapeutic efficacy of topic treatment with TvEO before and after 3 
and 7 days in ovine affected by MPD 
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Conclusions 
This study documents for the first time the effectiveness of TvEO for topical use in ovine affected 
by MPD. It is important to note that the follow-up with TvEO (7 days) is quite short as it is not an 
antibiotic and the speed of therapeutic effect is related to the high content of antioxidant 
substances, which possess antimicrobial, antifungal, anti-inflammatory effects, etc., as reported in 
literature. Therefore, the topical use of EOs on the skin and mucous membranes appears to be the 
most promising strategy to prevent or treat skin infections. However, further studies are needed, in 
particular on a greater number of cases and also on other diseases of farm breeding, to better 
evaluate therapeutic efficacy of TvEO in sheep. 
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